Opioids in Neuropathic Pain
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3013-3025
Author(s):
R. Przewlocki and B. Przewlocka
The Role of Newer Antiglutamatergic Agents as Mood-Stabilizers in Bipolar Disorder
Journal:
Current Drug Targets
Volume:
6
Page:
607-614
Author(s):
Marianna Abelli, Claudia Martini, Stefano Pini, Camilla Gesi and Giovanni B. Cassano
Diabetic Vascular Complications: Pathophysiology, Biochemical Basis and Potential Therapeutic Strategy
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2279-2299
Author(s):
Sho-ichi Yamagishi and T. Imaizumi
Microcirculation of the Diabetic Foot
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2301-2309
Author(s):
T. Dinh and A. Veves
Oxidative-Nitrosative Stress as a Contributing Factor to Cardiovascular Disease in Subjects with Diabetes
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
253-266
Author(s):
Martin J. Stevens
Role for Poly(ADP-ribose) Polymerase Activation in Diabetic Nephropathy, Neuropathy and Retinopathy
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
267-283
Author(s):
Irina G. Obrosova and Ulrich A. Julius
The Role of AGEs and AGE Inhibitors in Diabetic Cardiovascular Disease
Journal:
Current Drug Targets
Volume:
6
Page:
453-474
Author(s):
M. C. Thomas, J. W. Baynes, S. R. Thorpe and M. E. Cooper
Aldose Reductase in Diabetic Microvascular Complications
Journal:
Current Drug Targets
Volume:
6
Page:
475-486
Author(s):
S. S.M. Chung and S. K. Chung
Mechanisms of Neuropathic Pain
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
5
Page:
129-140
Author(s):
Tony L. Yaksh and Linda S. Sorkin
The Dual Transporter Inhibitor Duloxetine: A Review of its Preclinical Pharmacology, Pharmacokinetic Profile, and Clinical Results in Depression
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1475-1493
Author(s):
Frank P. Bymaster, Thomas C. Lee, Mary Pat Knadler, Michael J. Detke and Smriti Iyengar